How Long Does Semaglutide Take to Work?

Semaglutide starts affecting your appetite within days of the first dose, but meaningful weight loss takes weeks to months to accumulate. Understanding the realistic timeline helps set proper expectations and prevents premature discouragement. Based on clinical trial data from the STEP program and real-world patient outcomes, here is exactly what to expect at each stage of treatment with semaglutide (Ozempic, Wegovy, or compounded semaglutide).

The Short Answer

Semaglutide begins working pharmacologically within 1-3 days of your first injection. Most patients notice reduced appetite within the first 1-2 weeks. Visible weight loss typically becomes apparent within 4-8 weeks. Maximum weight loss is generally reached at 12-18 months of continuous treatment at the full maintenance dose. However, the trajectory varies significantly based on your starting dose, titration speed, diet, exercise, and individual biology.

Week-by-Week Timeline

Week 1-2: The Starting Dose (0.25 mg)

The initial dose of semaglutide is intentionally sub-therapeutic for weight loss. At 0.25 mg per week, the primary goal is to allow your body to begin adjusting to the medication and minimize gastrointestinal side effects. What most patients experience:

• Appetite: Mild to moderate reduction in appetite. Many patients notice they feel full sooner at meals, forget about snacks, or feel less interest in food between meals. This effect varies widely; some people notice it immediately, while others feel little change at this dose.
• Weight: 0-2 pounds lost, though water weight fluctuations can obscure any fat loss at this early stage.
• Side effects: Mild nausea (if any) is the most common side effect. It typically peaks 1-2 days after injection and subsides. Some patients experience no side effects at this dose.
• Blood sugar: For patients with diabetes or prediabetes, blood sugar improvements may begin within the first week, as semaglutide directly enhances insulin secretion.

Week 3-4: Still at 0.25 mg or Titrating to 0.5 mg

Most prescribing protocols keep patients at 0.25 mg for 4 weeks before increasing. Some patients are titrated to 0.5 mg at the 2-week mark. By the end of month one:

• Appetite: More consistent appetite suppression as the drug reaches steady-state concentration (semaglutide has a half-life of about 1 week, so it takes approximately 4-5 weeks to reach steady state at any given dose).
• Weight: 2-5 pounds lost for most patients. Some patients, particularly those with higher starting weights, may see more.
• Energy: Some patients report improved energy levels as they reduce caloric intake. Others feel slightly fatigued during the adjustment period.
• Cravings: Reduced food cravings, particularly for high-calorie and high-sugar foods, are commonly reported by the end of month one.

Month 2 (Weeks 5-8): Dose Escalation to 0.5-1.0 mg

This is where most patients begin to see noticeable, measurable progress:

• Appetite: Significantly reduced. Many patients describe a fundamentally different relationship with food, eating to satisfy genuine hunger rather than out of habit, boredom, or emotional triggers.
• Weight: 5-10 pounds lost from baseline. Clothes may begin fitting differently. Others may notice your weight loss.
• Side effects: Nausea may return briefly with each dose increase but typically resolves faster than at initial exposure. Constipation becomes more common at higher doses; adequate hydration and fiber intake help.
• Behavioral changes: Smaller portions, fewer snacks, reduced alcohol interest, and more intentional food choices become noticeable patterns.

Month 3-4 (Weeks 9-16): Reaching Higher Doses (1.0-1.7 mg)

The titration continues, and weight loss accelerates for most patients:

• Weight: 8-15 pounds lost from baseline. In clinical trials, participants lost approximately 5-7% of body weight by month 3-4.
• Body composition: If combined with resistance training, patients begin to see visible changes in body shape beyond just scale numbers.
• Metabolic markers: Blood pressure, triglycerides, and fasting glucose often show measurable improvement by this point.
• Confidence building: Many patients report that seeing consistent progress strengthens their commitment to the lifestyle changes that complement the medication.

Month 5-8 (Weeks 17-32): Maintenance Dose (2.0-2.4 mg)

Patients reaching the full Wegovy dose of 2.4 mg (or staying at 2.0 mg for Ozempic) are now at the dose where clinical trial data is most robust:

• Weight: 10-15% of starting body weight lost. For a 220-pound person, that is 22-33 pounds.
• Weight loss rate: The pace slows compared to earlier months, typically settling to 1-2 pounds per week. This is normal and expected, not a plateau.
• Side effects: Gastrointestinal side effects have typically stabilized or resolved for most patients by this point.

Month 9-18: Peak Weight Loss

Based on STEP 1 data, weight loss continues but at a decelerating rate through approximately month 14-16, at which point most patients reach their nadir (maximum weight loss):

• Weight: Average of 15-17% total body weight lost (STEP 1 trial result). Top responders may lose 20%+ of body weight.
• Plateau: Weight stabilizes as caloric intake and energy expenditure reach a new equilibrium. This is not drug tolerance; it is a new biological set point.

Average Weight Loss Timeline Summary

Note: These are averages from clinical trials. Individual results vary significantly based on starting weight, diet, exercise, genetics, and other factors.

Factors That Affect How Quickly Semaglutide Works

Titration Speed

Faster titration (reaching the maintenance dose sooner) generally produces faster weight loss, but at the cost of more severe gastrointestinal side effects and higher dropout rates. The standard Wegovy titration takes 16-20 weeks to reach 2.4 mg. Your provider may adjust this based on your tolerance. Do not attempt to titrate faster without medical guidance.

Diet and Exercise

Semaglutide enhances weight loss from dietary changes but does not replace them. In the STEP 1 trial, all participants received lifestyle counseling including a 500-calorie-per-day deficit and 150 minutes of weekly physical activity. Patients who combine semaglutide with meaningful exercise and dietary improvements typically see faster and greater weight loss.

Starting Weight and BMI

Patients with higher starting weights tend to lose more total pounds but a similar percentage of body weight. A 300-pound patient losing 17% loses 51 pounds; a 200-pound patient losing 17% loses 34 pounds. The percentage-based trajectory is fairly consistent across starting weights in clinical trial data.

Individual Biology

Genetic variation in GLP-1 receptor sensitivity, metabolic rate, gut microbiome composition, and hormonal profiles all influence individual response. Approximately 10-15% of patients are classified as "poor responders," losing less than 5% of body weight after 6 months at full dose. This is not a failure of effort; it reflects biological variation.

Signs Semaglutide Is Working (Beyond the Scale)

Weight is not the only indicator of progress. Look for these signs that semaglutide is doing its job:

• Reduced hunger between meals: You go longer between meals without thinking about food.
• Smaller portions feel satisfying: You feel comfortably full after eating less than before.
• Fewer food cravings: Particularly for high-sugar and high-fat foods.
• Improved blood sugar readings: If you monitor blood glucose.
• Better energy levels: As weight decreases and metabolic health improves.
• Improved sleep quality: Particularly if you had sleep apnea or weight-related sleep disturbances.
• Lower blood pressure: Weight loss of even 5% can meaningfully reduce blood pressure.

When to Talk to Your Doctor About Adjustments

Consider contacting your healthcare provider if:

• You have been at the same dose for 8+ weeks with zero appetite change or weight loss.
• Side effects are preventing you from eating enough to meet basic nutritional needs.
• You experience severe or persistent nausea, vomiting, or abdominal pain.
• Weight loss has completely stalled for more than 6-8 weeks at the maximum dose (a true plateau may warrant evaluation of other factors).
• You have lost significantly more weight than expected and are approaching or below a healthy BMI.

At Trimi, our clinical team provides ongoing monitoring and dose adjustments as part of every treatment plan. If you are not seeing the results you expect, explore our treatment options for personalized support.

Frequently Asked Questions

How much weight can I lose in the first month on semaglutide?

Most patients lose 2-5 pounds in the first month, though this varies. The starting dose of 0.25 mg is intentionally low to allow your body to adjust, so significant weight loss typically begins once you reach higher doses in months 2-3. Some patients lose more in the first month due to water weight changes and reduced caloric intake.

Why am I not losing weight on semaglutide?

If you are early in treatment (first 4-8 weeks), you may still be on a sub-therapeutic dose. Give the titration process time. If you have been at the maximum dose for 8+ weeks without progress, factors to evaluate include: caloric intake (even with reduced appetite, calorie-dense foods can prevent a deficit), fluid retention, hormonal factors (thyroid function, cortisol), and whether your expectations align with clinical averages. Discuss these with your provider.

Does semaglutide work right away for appetite?

Many patients notice mild appetite reduction within the first week, even at the 0.25 mg starting dose. However, because it takes approximately 4-5 weeks for semaglutide to reach steady-state blood levels at any given dose, the appetite-suppressing effect becomes stronger and more consistent over the first month. Significant appetite suppression typically corresponds with doses of 1.0 mg and above.

What is the maximum weight loss on semaglutide?

In STEP 1, the average maximum weight loss was approximately 15-17% of body weight at 68 weeks. However, individual results ranged widely: some participants lost over 20%, while others lost less than 5%. There is no fixed ceiling; a small percentage of patients in clinical trials lost more than 25% of their body weight. Your individual maximum depends on dose, lifestyle factors, and biology.

Is Ozempic weight loss slower than Wegovy?

Potentially, yes. Ozempic maxes out at 2.0 mg, while Wegovy goes to 2.4 mg. The additional 0.4 mg provides incremental weight loss benefit. Additionally, Ozempic is approved for type 2 diabetes (not weight loss), so the titration schedule and clinical context may differ. Many patients use compounded semaglutide or work with providers like Trimi to access weight-loss-appropriate dosing.

When should I expect to see my best results on semaglutide?

Based on clinical trial data, most patients reach their maximum weight loss between months 12 and 16 of continuous treatment at the full dose. This means if you start today and follow the standard titration, your peak results are approximately 16-20 months away (including 4-5 months of titration). The journey is a marathon, not a sprint, but the results are well worth the patience.